Table 1. Demographic and Clinical Characteristics of Survivors by Diagnostic Group.
| BT Survivors |
ALL Survivors |
|||
|---|---|---|---|---|
| Characteristic | n | % | n | % |
| Total | 48 | 100.00 | 50 | 100.00 |
| Sex | ||||
| Female | 24 | 50.00 | 25 | 50.00 |
| Male | 24 | 50.00 | 25 | 50.00 |
| Race/ethnicity | ||||
| White, non-Hispanic | 41 | 85.42 | 43 | 86.00 |
| Non-White | 7 | 14.58 | 7 | 14.00 |
| Cranial radiation therapy | ||||
| No | 9 | 18.75 | 43 | 86.00 |
| Yes | 39 | 81.25 | 7 | 14.00 |
| CSI | ||||
| No | 30 | 62.50 | 48 | 96.00 |
| Yes | 18 | 37.50 | 2 | 4.00 |
| Chemotherapy | ||||
| No | 23 | 47.92 | 0 | 0.00 |
| Yes | 25 | 52.08 | 50a | 100.00 |
| Neurosurgery | ||||
| No | 4 | 8.33 | 50 | 100.00 |
| Yes | 44 | 91.67 | 0 | 0.00 |
| Shunt | ||||
| No | 35 | 72.92 | 50 | 100.00 |
| Yes | 13 | 27.08 | 0 | 0.00 |
|
|
|
|||
| M ± SD | Range | M ± SD | Range | |
|---|---|---|---|---|
|
|
|
|||
| Age at study participation |
14.91 ± 1.79 | 12.06-17.99 | 14.95 ±2.00 | 12.16-17.99 |
| Age at diagnosis | 8.12 ± 3.61 | 1.95-15.21 | 4.97 ± 3.09 | 0.65-12.95 |
| Years from diagnosis | 6.79 ± 4.02 | 1.74-16.02 | 9.98 ± 3.04 | 4.64-16.93 |
| Years off treatment | 5.60 ± 3.66 | 1.11-16.02 | 7.07 ± 3.28 | 1.52-15.48 |
Note. Some survivors are represented in more than one treatment category. Cranial radiation therapy includes any irradiation to the brain (i.e., focal, whole brain, and craniospinal). CSI = craniospinal irradiation.
a
All ALL survivors received intrathecal chemotherapy.